Das BiLe-Trial – eine randomisierte, kontrollierte multizentrische Studie zum Vergleich der Rate an Gallenleckage mit oder ohne intraoperativer Durchführung des „White Tests“ (Verabreichung von 20-40ml SMOFlipid in das Gallengangssystem) nach Leberresektion

Drug: "white" test" (= the administration of SMOFlipid retrograde through the cystic duct)

Gender: All
Maximum age: N/A
Minimum age: 18 Years

Inclusion Criteria:

- Patients who will receive an anatomical resection of two or more liver segments for
any reason with simultaneous cholecystectomy in elective Setting

- Patients who will receive an anatomical resection of two or more liver segments for
any reason which already had a cholecystectomy if intraoperatively the cystic stump
can be identified and opened

- Ability of subject to understand character and individual consequences of the clinical
Trial

- Informed consent documented by signature

Exclusion Criteria:

- Previous cholecystectomy if intraoperative it is not possible to identify the cystic
stump

- Intraoperative hepatico-jejunostomy

- Hypersensitivity to fish-, egg-, soybean or peanut protein or to any of the active
ingredients or excipients

- Immunosuppression, pregnancy

- Emergency liver resection because of traumatic liver rupture

- Enrolment of the investigator, his/her family members, employees and other dependent
persons